Kristeleit RS, Drew Y, Oza AM, Domchek SM, et al. Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 10. Br J Cancer 2022 Dec 8. doi: 10.1038/s41416-022-02022.
PMID: 36482193